These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 12592151)

  • 1. [Nuchal translucency: technical measurement and value].
    Broussin B; Sarramon MF
    J Radiol; 2002 Dec; 83(12 Pt 2):1891-8. PubMed ID: 12592151
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Screening for Down syndrome using first-trimester ultrasound and second-trimester maternal serum markers in a low-risk population: a prospective longitudinal study.
    Audibert F; Dommergues M; Benattar C; Taieb J; Thalabard JC; Frydman R
    Ultrasound Obstet Gynecol; 2001 Jul; 18(1):26-31. PubMed ID: 11489221
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of first-trimester nuchal translucency on second-trimester maternal serum biochemical screening for Down's syndrome.
    Thilaganathan B; Slack A; Wathen NC
    Ultrasound Obstet Gynecol; 1997 Oct; 10(4):261-4. PubMed ID: 9383877
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Pregnancy outcome in 1,252 fetuses after nuchal translucency measurement in the 1st trimester].
    Horner E; Holzgreve W; Batucan C; Tercanli S
    Praxis (Bern 1994); 2002 Feb; 91(7):261-5. PubMed ID: 11883361
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Screening for Down's syndrome by fetal nuchal translucency measurement in a high-risk population.
    Pajkrt E; Mol BW; van Lith JM; Bleker OP; Bilardo CM
    Ultrasound Obstet Gynecol; 1998 Sep; 12(3):156-62. PubMed ID: 9793186
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Screening for Down's syndrome by fetal nuchal translucency measurement in a general obstetric population.
    Pajkrt E; van Lith JM; Mol BW; Bleker OP; Bilardo CM
    Ultrasound Obstet Gynecol; 1998 Sep; 12(3):163-9. PubMed ID: 9793187
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nuchal translucency measurement in first trimester Down syndrome screening.
    Scott A
    Issues Emerg Health Technol; 2007 Jun; (100):1-6. PubMed ID: 17595751
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sequential screening for trisomy 21 by nuchal translucency measurement in the first trimester and maternal serum biochemistry in the second trimester in a low-risk population.
    Schuchter K; Hafner E; Stangl G; Ogris E; Philipp K
    Ultrasound Obstet Gynecol; 2001 Jul; 18(1):23-5. PubMed ID: 11489220
    [TBL] [Abstract][Full Text] [Related]  

  • 9. First trimester nuchal translucency: effective routine screening for Down's syndrome.
    Thilaganathan B; Sairam S; Michailidis G; Wathen NC
    Br J Radiol; 1999 Oct; 72(862):946-8. PubMed ID: 10673944
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ultrasonographic markers for chromosomal abnormalities in women with negative nuchal translucency and second trimester maternal serum biochemistry.
    Verdin SM; Whitlow BJ; Lazanakis M; Kadir RA; Chatzipapas I; Economides DL
    Ultrasound Obstet Gynecol; 2000 Oct; 16(5):402-6. PubMed ID: 11169322
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Measurement of nuchal translucency as a single strategy in trisomy 21 screening: should we use any other marker?
    Comas C; Torrents M; Muñoz A; Antolín E; Figueras F; Echevarría M
    Obstet Gynecol; 2002 Oct; 100(4):648-54. PubMed ID: 12383528
    [TBL] [Abstract][Full Text] [Related]  

  • 12. First-trimester screening for Down syndrome in France combining fetal nuchal translucency measurement and biochemical markers.
    Muller F; Benattar C; Audibert F; Roussel N; Dreux S; Cuckle H
    Prenat Diagn; 2003 Oct; 23(10):833-6. PubMed ID: 14558029
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Sonographic first trimester screening in Switzerland].
    Lapaire O; Sartorius G; Holzgreve W; Tercanli S
    Praxis (Bern 1994); 2005 Feb; 94(6):199-204. PubMed ID: 15754531
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fetal nuchal translucency screening in 12495 pregnancies in Sardinia.
    Zoppi MA; Ibba RM; Floris M; Monni G
    Ultrasound Obstet Gynecol; 2001 Dec; 18(6):649-51. PubMed ID: 11844208
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Integrated ultrasound and biochemical screening for trisomy 21 using fetal nuchal translucency, absent fetal nasal bone, free beta-hCG and PAPP-A at 11 to 14 weeks.
    Cicero S; Bindra R; Rembouskos G; Spencer K; Nicolaides KH
    Prenat Diagn; 2003 Apr; 23(4):306-10. PubMed ID: 12673635
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of nuchal translucency measurement on second-trimester biochemical screening for Down's syndrome.
    Kadir RA; Economides DL
    Ultrasound Obstet Gynecol; 1997 Apr; 9(4):244-7. PubMed ID: 9168574
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Screening for trisomy 21 by fetal nuchal translucency and maternal age: a multicenter project in Germany, Austria and Switzerland.
    Gasiorek-Wiens A; Tercanli S; Kozlowski P; Kossakiewicz A; Minderer S; Meyberg H; Kamin G; Germer U; Bielicki M; Hackelöer BJ; Sarlay D; Kuhn P; Klapp J; Bahlmann F; Pruggmayer M; Schneider KT; Seefried W; Fritzer E; von Kaisenberg CS;
    Ultrasound Obstet Gynecol; 2001 Dec; 18(6):645-8. PubMed ID: 11844207
    [TBL] [Abstract][Full Text] [Related]  

  • 18. First-trimester screening for aneuploidy with fetal nuchal translucency in a United States population.
    Chasen ST; Sharma G; Kalish RB; Chervenak FA
    Ultrasound Obstet Gynecol; 2003 Aug; 22(2):149-51. PubMed ID: 12905508
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Natural history of trisomy 21 fetuses with increased nuchal translucency thickness.
    Pandya PP; Snijders RJ; Johnson S; Nicolaides KH
    Ultrasound Obstet Gynecol; 1995 Jun; 5(6):381-3. PubMed ID: 7552798
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Down syndrome screening by ultrasound].
    Rozenberg P
    Gynecol Obstet Fertil; 2005; 33(7-8):526-32. PubMed ID: 16005667
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.